5 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications Summary ... Table Insulin ... GLP-1 receptor agonists ... - Strong Medicine ... #medications #table
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockers⠀
Class II
Vaughan Williams Classification ... - Summary Table ... Eric Strong @DrEricStrong ... - Strong Medicine ... #Summary #Table
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology Summary ... Ozempic), or daily tablet ... variety of adverse CV ... - Strong Medicine
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology Summary ... Vaughan Williams Classification ... : CLASS 1 - Sodium ... 1C: Strong Blockade ... #Pharmacology #Classification
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
b) CHF c) CVA ... ASA class If ... event, follow ACC algorithm ... Stable patients ... • <6mo since stroke